Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,371,575
-
Total 13F shares
-
19,690,795
-
Share change
-
-957,508
-
Total reported value
-
$94,319,000
-
Price per share
-
$4.79
-
Number of holders
-
21
-
Value change
-
-$5,245,378
-
Number of buys
-
7
-
Number of sells
-
15
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q3 2020
As of 30 Sep 2020,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,690,795 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C., Aquilo Capital Management, LLC, DAFNA Capital Management LLC, Artal Group S.A., ALTRINSIC GLOBAL ADVISORS LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, and FRANKLIN STREET ADVISORS INC /NC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.